Baker Bros. Capital (GP), LLC Insider Trading $ALTH ALLOS THERAPEUTICS INC
Get free email notifications about insider trading for Baker Bros. Capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Baker Bros. Capital (GP), LLC. Baker Bros. Capital (GP), LLC is 10% Owner in HERON THERAPEUTICS, INC. /DE/ ($HRTX) and 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in INCYTE CORP ($INCY) and Director in NEUROGEN CORP ($NRGN) and 10% Owner in IDERA PHARMACEUTICALS, INC. ($IDRA) and 10% Owner in TAPESTRY PHARMACEUTICALS, INC ($NPRO) and 10% Owner in VIROPHARMA INC ($VPHM) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in ADOLOR CORP ($ADLR) and 10% Owner in ALLOS THERAPEUTICS INC ($ALTH) and 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL).
Baker Bros. Capital (GP), LLC in ALLOS THERAPEUTICS INC
Trading Symbol: ALTHIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Bros. Capital (GP), LLC: 10% Owner
Holdings: 1,629 shares
Latest Transaction: Feb 06 2009
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Baker Bros. Capital (GP), LLC in ALLOS THERAPEUTICS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADLR, ALTH, IBPI, AUXL, BCRX, GHDX, HRTX, IDRA, INCY, NRGN, SGEN, GEVA, NPRO, VPHM
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 8.17 | 212 | 1,733 | 1,629 | 1.8 K to 1.6 K (-11.52 %) |
Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 8.11 | 40 | 324 | 1,841 | 1.9 K to 1.8 K (-2.13 %) |
Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 8.17 | 10 | 82 | 1,881 | 1.9 K to 1.9 K (-0.53 %) |
Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 8.16 | 55 | 449 | 1,891 | 1.9 K to 1.9 K (-2.83 %) |
Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 8.46 | 207 | 1,751 | 1,946 | 2.2 K to 1.9 K (-9.61 %) |
Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 8.47 | 22 | 186 | 2,153 | 2.2 K to 2.2 K (-1.01 %) |
Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 9.03 | 2 | 18 | 2,175 | 2.2 K to 2.2 K (-0.09 %) |
Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 8.01 | 81 | 649 | 2,177 | 2.3 K to 2.2 K (-3.59 %) |
Jan 23 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | J | 0.00 | 2,901 | 0 | 2,258 | 5.2 K to 2.3 K (-56.23 %) |
Jan 23 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | J | 0.00 | 72,217 | 0 | 5,159 | 77.4 K to 5.2 K (-93.33 %) |
May 30 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | J | 0.00 | 4,610 | 0 | 77,376 | 82 K to 77.4 K (-5.62 %) |
May 30 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | J | 0.00 | 109,834 | 0 | 81,986 | 191.8 K to 82 K (-57.26 %) |
Feb 27 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 6.00 | 91 | 546 | 191,820 | 191.7 K to 191.8 K (+0.05 %) |
Feb 21 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 6.20 | 64 | 397 | 191,729 | 191.7 K to 191.7 K (+0.03 %) |
Feb 21 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 5.90 | 68 | 401 | 191,665 | 191.6 K to 191.7 K (+0.04 %) |
Feb 21 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 6.50 | 104 | 676 | 191,597 | 191.5 K to 191.6 K (+0.05 %) |
Feb 21 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 6.75 | 103 | 696 | 191,493 | 191.4 K to 191.5 K (+0.05 %) |
Jan 23 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 6.95 | 53 | 368 | 191,390 | 191.3 K to 191.4 K (+0.03 %) |
Jan 23 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 6.92 | 1 | 7 | 191,337 | 191.3 K to 191.3 K (0.00 %) |
Jan 23 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 7.15 | 11 | 79 | 191,336 | 191.3 K to 191.3 K (+0.01 %) |
Jan 23 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 7.22 | 12 | 87 | 191,325 | 191.3 K to 191.3 K (+0.01 %) |
Jan 17 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 7.50 | 47 | 353 | 191,313 | 191.3 K to 191.3 K (+0.02 %) |
Jan 14 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 7.41 | 245 | 1,817 | 191,266 | 191 K to 191.3 K (+0.13 %) |
Jan 14 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 7.47 | 103 | 770 | 191,021 | 190.9 K to 191 K (+0.05 %) |
Jan 14 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 7.47 | 218 | 1,628 | 190,918 | 190.7 K to 190.9 K (+0.11 %) |
Jan 09 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 6.96 | 117 | 814 | 190,700 | 190.6 K to 190.7 K (+0.06 %) |
Jan 09 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 7.21 | 376 | 2,712 | 190,583 | 190.2 K to 190.6 K (+0.20 %) |
Jan 09 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 6.85 | 188 | 1,288 | 190,207 | 190 K to 190.2 K (+0.10 %) |
Jan 09 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 6.37 | 2 | 13 | 190,019 | 190 K to 190 K (0.00 %) |
Jun 21 2007 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 5.55 | 1,950 | 10,825 | 190,017 | 192 K to 190 K (-1.02 %) |
Jun 21 2007 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 5.85 | 3,880 | 22,688 | 191,967 | 195.8 K to 192 K (-1.98 %) |
Jun 21 2007 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 5.64 | 16,450 | 92,747 | 195,847 | 212.3 K to 195.8 K (-7.75 %) |
Jun 21 2007 | ALTH | ALLOS THERAPEUTICS ... | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 5.76 | 3,545 | 20,406 | 212,297 | 215.8 K to 212.3 K (-1.64 %) |
Page: 1